Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020–2022): A retrospective longitudinal SARS-CoV-2 serological surveillance-Reference-Cited by-同舟云学术

Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020–2022): A retrospective longitudinal SARS-CoV-2 serological surveillance

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

De Pace Vanessa¹,Bruzzone Bianca¹,Ricucci Valentina¹,Calcavecchia Nicola²,Guarona Giulia²,Giberti Irene²,Costa Elisabetta²,Ogliastro Matilde²,Galano Barbara¹,Nigro Nicola¹,Murgia Daniele³,Nanni Luca³,Orsi Andrea¹²

Affiliation:

1. Hygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy

2. Department of Health Sciences, University of Genoa, Genoa, Italy

3. Medicine Laboratory, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy

Funder

no funding associated

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2258632

Reference43 articles.

1. World Health Organization. Coronavirus (COVID-19) dashboard. [accessed 2023 Aug 7]. https://covid19.who.int/.

2. Centers for Disease Control and Prevention. COVID-19. [accessed 2023 Aug 7]. https://www.cdc.gov/coronavirus/2019-nCoV/index.html.

3. BNT162b2 mRNA COVID-19 Vaccine: First Approval

4. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

5. New drug: BNT162b2 vaccine for prevention of COVID-19

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers;Vaccines;2023-12-19